Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 6, 1997, Pages 855-862

  Groll, Andreas H ^a,b   Just Nuebling, Gudrun ^a   Kurz, Marianne ^a   Mueller, Constanze ^a,c   Nowak Goettl, Ulrike ^a,d   Schwabe, Dirk ^a   Shah, Pramod M ^a   Kornhuber, Bernhard ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c City Hospital Hanau   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; NYSTATIN;

ADOLESCENT; ARTICLE; CANCER; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDIASIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FECES; FEMALE; FLUCONAZOLE; HUMANS; INFANT; MALE; NEOPLASMS; NYSTATIN; OROPHARYNX; PROSPECTIVE STUDIES; PRURITUS;

EID: 0031437145     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.6.855     Document Type: Article

References (34)

1. Walsh, T. J., Hiemenz, J. W. & Anaissie E. (1996). Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infectious Disease Clinics of North America 10, 365-400.
2. Samonis, G., Rolston, K., Karl, C., Miller, P. & Bodey, G. P. (1990). Prophylaxis of oropharyngeal candidiasis with fluconazole. Reviews of Infectious Diseases 12, Suppl. 3, S369-73.
3. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-51.
4. Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H. et al. (1993). Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled double-blind multicenter trial. Annals of Internal Medicine 118, 495-503.
5. Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R. et al. (1995). Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation - a prospective randomized double-blind study. Journal of Infectious Diseases 171, 1545-52.
6. Groll, A., Shah, P. M., Mentzel, C., Schneider, M., Just-Nuebling, G. & Huebner, K. (1996). Trends in the postmortem epidemiology of invasive fungal infections at an university hospital. Journal of Infection 33, 23-32.
7. Goodrich, J. M., Reed, E. C., Mori, M., Fisher, L. D., Skerett, S., Dandliker, P. S. et al. (1991). Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. Journal of Infectious Diseases 164, 731-40.
8. Marina, N. M., Flynn, P. M., Rivera, G. K. & Hughes, W. T. (1991). Candida tropicalis and Candida albicans fungemia in children with leukemia. Cancer 68, 594-9.
9. Lecciones, J. A., Lee, J. W., Navarro, E. E., Witebsky, F. G., Marshall, D., Steinberg, S. M. et al. (1992). Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clinical Infectious Diseases 14, 875-83.
10. Meunier, F., Aoun, M. & Bitar, N. (1992). Candidemia in immunocompromised patients. Clinical Infectious Diseases 14, Suppl. 1, S120-5.
11. Besnard, M., Hartmann, O., Valteau-Couanet, D., Robert, M. C., Brugieres, L. & Lemerle, J. (1993). Systemic Candida infection in pediatric BM-autotransplantation: clinical signs, outcome and prognosis. Bone Marrow Transplantation 11, 465-70.
12. Klingspor, L., Stintzing, G., Fasth, A. & Tollemar, J. (1996). Deep Candida infection in children receiving allogeneic bone marrow transplants: incidence, risk factors and diagnosis. Bone Marrow Transplantation 17, 1043-9.
13. Uzun, O. & Anaissie, E. J. (1995). Antifungal prophylaxis in patients with hematological malignancies: a reappraisal. Blood 86, 2063-72.
14. Schaison, G., Baruchel, A. & Arlet, G. (1990). Prevention of Gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children. British Journal of Haematology 76, Suppl. 2, 24-6.
15. Cap, J., Mojzesova, A., Kayserova, E., Bubanska, E., Trupl, J. & Krcmery, V. (1993). Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer. Chemotherapy 39, 438-42.
16. Cesaro, S., Rosseti, F., Perilongo, G., Rossi, L. & Zanesco, L. (1993). Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies. Hematologica 78, 249-51.
17. Ninane, J. & a Multicentre Study Group. (1994). A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infections in children with hematological or oncological malignancies. European Journal of Clinical Microbiology and Infectious Diseases 13, 330-7.
18. Philpott-Howard, J. N., Wade, J. J., Mufti, G. J., Brammer, K. W., Ehninger, G. & a Multicentre Study Group (1993). Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infections in patients at risk of neutropenia. Journal of Antimicrobial Chemotherapy 31, 973-84.
19. Menichetti, F., Del Favero, A., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D. et al. (1994). Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Annals of Internal Medicine 120, 913-8.
20. Ellis, M. E., Clink, H., Ernst, P., Halim, M. A., Padmos, A., Spence, D. et al. (1994). Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with hematological malignancies and bone marrow transplant recipients. European Journal of Clinical Microbiology and Infectious Diseases 13, 3-11.
21. Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E., O'Brien, S. & Kantarjian, H. (1994). Antifungal prophylaxis during remission induction therapy for acute leukemia. Fluconazole versus intravenous amphotericin B. Cancer 73, 2099-106.
22. Wiley, J. M., Smith, N., Leventhal, B. G., Graham, M. L., Strauss, L. C., Hurwitz, C. A. et al. (1990). Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. Journal of Clinical Oncology 8, 280-6.
23. Stinnett, E. A., Childers, N. K., Wright, J. T., Rodu, B. K. & Bradley, E. L. (1992). The detection of oral Candida in pediatric leukemia patients. Pediatric Dentistry 14, 236-9.
24. Childers, N. K., Stinnet, E. A., Wheeler, P., Wright, J. T., Castleberry, R. P. & Dasanayake, A. P. (1993). Oral complications in children with cancer. Oral Surgery, Oral Medicine, Oral Pathology 75, 41-7.
25. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991) Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.
26. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E. & Saral, R. (1993). Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrobial Agents and Chemotherapy 37, 1847-9.
27. Viscoli, C., Castagnola, E., Fioredda, F., Ciravegna, B., Barigione, G. & Terragna, A. (1991). Fluconazole in the treatment of candidiasis in immunocompromised children. Antimicrobial Agents and Chemotherapy 35, 365-7.
28. Groll, A., Nowak-Gottl, U., Wildfeuer, A., Weise, M., Schwabe, D., Gerein, V. et al. (1992). Fluconazole treatment of oropharyngeal candidosis in pediatric cancer patients with severe mucositis following antineoplastic chemotherapy. Mycoses 35, Suppl., 35-40.
29. Lee, J. W., Seibel, N. L., Amantea, A. M., Whitcomb, P., Pizzo, P. A. & Walsh, T. J. (1992). Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. Journal of Pediatrics 120, 987-93.
30. Fasano, C., O'Keefe, J. & Gibbs, D. (1994). Fluconazole treatment of children with severe fungal infections not treatable with conventional agents. European Journal of Clinical Microbiology and Infectious Diseases 13, 344-7.
31. Hernandez-Sampelayo, T. & a Multicenter Study Group (1994). Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. European Journal of Clinical Microbiology and Infectious Diseases 13, 340-4.
32. Marchisio, P., Principi, N. & a Multicentre Study Group. (1994). Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. European Journal of Clinical Microbiology and Infectious Diseases 13, 338-40.
33. Flynn, P. M., Cunningham, C. K., Kerkering, T., San Jorge, A. R., Peters, V. B., Pitel, P. A. et al. (1995). Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. Journal of Pediatrics 127, 322-8.
34. Seay, R. E., Larson, T. A., Toscano, J. P., Bostrom, B. C., O'Leary, M. C. & Uden, D. L. (1995). Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases. Pharmacotherapy 15, 52-8.